ACS chemical neuroscience molecule spotlight on latuda (lurasidone; SM-13,496).
Department of Pharmacology and Vanderbilt Program in Drug Discovery, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232-6600, USA.
Corey R
CR
Hopkins
D000818:Animals; D014150:Antipsychotic Agents / Q000737:chemistry* / Q000378:metabolism / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D018492:Dopamine Antagonists / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D054833:Isoindoles / Q000737:chemistry* / Q000378:metabolism / Q000627:therapeutic use*; D000069056:Lurasidone Hydrochloride; D009488:Neurosciences; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism; D012702:Serotonin Antagonists / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D012958:Societies, Scientific; D013844:Thiazoles / Q000737:chemistry* / Q000378:metabolism / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D054833:Isoindoles; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D013844:Thiazoles; D000069056:Lurasidone Hydrochloride